Martin Nilsson

Sökresultat

• 2022

  Dosimetric and Clinical Predictors for Acute and Late Gastrointestinal Toxicity Following Chemoradiotherapy of Locally Advanced Anal Cancer

  Nilsson, M. P., Gunnlaugsson, A., Johnsson, A. & Scherman, J., 2022, I: Clinical Oncology. 34, 1, s. e35-e44

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Anus Neoplasms 100%
  • Chemoradiotherapy 77%
  • Area Under Curve 35%
  • Logistic Models 18%
  • Organs at Risk 18%
• 2021

  Genetic testing in women with early-onset breast cancer: a Traceback pilot study

  Augustinsson, A., Nilsson, M. P., Ellberg, C., Kristoffersson, U., Olsson, H. & Ehrencrona, H., 2021, I: Breast Cancer Research and Treatment. 190, 2, s. 307-315

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Genetic Testing 100%
  • Breast Neoplasms 61%
  • Genetic Counseling 35%
  • Sweden 31%
  • BRCA2 Gene 23%

• Patterns of pathologic lymph nodes in anal cancer: a PET-CT-based analysis with implications for radiotherapy treatment volumes

  Frennered, A., Scherman, J., Buchwald, P., Johnsson, A., Sartor, H., Zackrisson, S., Trägårdh, E. & Nilsson, M. P., 2021 dec, I: BMC Cancer. 21, 1, 9 s., 447.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Anus Neoplasms 100%
  • Positron Emission Tomography Computed Tomography 79%
  • Lymph Nodes 51%
  • Radiotherapy 50%
  • Groin 18%

• Sarcopenia and dosimetric parameters in relation to treatment-related leukopenia and survival in anal cancer

  Nilsson, M. P., Johnsson, A. & Scherman, J., 2021 dec, I: Radiation Oncology. 16, 1, 152.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Anus Neoplasms 100%
  • Sarcopenia 90%
  • Leukopenia 79%
  • Leukocytes 57%
  • Survival 40%
• 2020

  Breast cancer survival in Nordic BRCA2 mutation carriers—unconventional association with oestrogen receptor status

  Olafsdottir, E. J., Borg, A., Jensen, M. B., Gerdes, A. M., Johansson, A. L. V., Barkardottir, R. B., Johannsson, O. T., Ejlertsen, B., Sønderstrup, I. M. H., Hovig, E., Lænkholm, A. V., Hansen, T. V. O., Olafsdottir, G. H., Rossing, M., Jonasson, J. G., Sigurdsson, S., Loman, N., Nilsson, M. P., Narod, S. A. & Tryggvadottir, L., 2020 nov 24, I: British Journal of Cancer. 123, 11, s. 1608-1615 8 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Estrogen Receptors 100%
  • Breast Neoplasms 68%
  • Mutation 59%
  • Survival 59%
  • Iceland 24%

• Patterns of recurrence in anal cancer: A detailed analysis

  Nilsson, M. P., Nilsson, E. D., Johnsson, A., Leon, O., Gunnlaugsson, A. & Scherman, J., 2020 maj 27, I: Radiation Oncology. 15, 125.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Anus Neoplasms 100%
  • Recurrence 41%
  • Lymph Nodes 34%
  • Groin 24%
  • Radiotherapy 11%
  5 Citeringar (SciVal)
• 2019

  Breathing-motion induced interplay effects for stereotactic body radiotherapy of liver tumours using flattening-filter free volumetric modulated arc therapy

  Edvardsson, A., Scherman, J., Nilsson, M. P., Wennberg, B., Nordström, F., Ceberg, C. & Ceberg, S., 2019 jan 8, I: Physics in Medicine and Biology. 64, 2, 025006.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Intensity-Modulated Radiotherapy 100%
  • Radiosurgery 90%
  • Respiration 68%
  • Ventilation 48%
  • Liver 42%
  4 Citeringar (SciVal)

• High patient satisfaction with a simplified BRCA1/2 testing procedure: long-term results of a prospective study

  Nilsson, M. P., Nilsson, E. D., Borg, Å., Brandberg, Y., Silfverberg, B. & Loman, N., 2019, I: Breast Cancer Research and Treatment. 173, 2, s. 313-318

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Patient Satisfaction 100%
  • Genetic Counseling 77%
  • Prospective Studies 68%
  • Mutation 39%
  • Prophylactic Mastectomy 27%
  7 Citeringar (SciVal)

• Written pretest information and germline BRCA1/2 pathogenic variant testing in unselected breast cancer patients: predictors of testing uptake

  Nilsson, M. P., Nilsson, E. D., Silfverberg, B., Borg, Å. & Loman, N., 2019 jan, I: Genetics in Medicine. 21, 1, s. 89-96

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Breast Neoplasms 100%
  • Odds Ratio 72%
  • Medical Records 37%
  • Genetic Testing 23%
  • Occupations 22%
  3 Citeringar (SciVal)
• 2018

  BRCAsearch: written pre-test information and BRCA1/2 germline mutation testing in unselected patients with newly diagnosed breast cancer

  Nilsson, M. P., Törngren, T., Henriksson, K., Kristoffersson, U., Kvist, A., Silfverberg, B., Borg, Å. & Loman, N., 2018, I: Breast Cancer Research and Treatment. 168, 1, s. 117-126

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Germ-Line Mutation 100%
  • Genetic Counseling 58%
  • Breast Neoplasms 56%
  • Mutation 39%
  • Genetic Testing 36%
  9 Citeringar (SciVal)

• Germline mutations in BRCA1 and BRCA2 incidentally revealed in a biobank research study: experiences from re-contacting mutation carriers and relatives

  Nilsson, M. P., Emmertz, M., Kristoffersson, U., Borg, Å., Larsson, C., Rehn, M., Winter, C., Saal, L. H., Brandberg, Y. & Loman, N., 2018 jul, I: Journal of Community Genetics. 9, 3, s. 201-208

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Germ-Line Mutation 100%
  • Mutation 49%
  • Research Personnel 30%
  • Bioethics 30%
  • experience 27%
  2 Citeringar (SciVal)
• 2017

  Efficacy versus effectiveness of clinical genetic testing criteria for BRCA1 and BRCA2 hereditary mutations in incident breast cancer

  Nilsson, M. P., Winter, C., Kristoffersson, U., Rehn, M., Larsson, C., Saal, L. H. & Loman, N., 2017 apr, I: Familial Cancer. 16, 2, s. 187-193

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Genetic Testing 100%
  • Breast Neoplasms 61%
  • Mutation 54%
  • Germ-Line Mutation 27%
  • Patient Selection 21%
  12 Citeringar (SciVal)
• 2016

  Is Breast-conserving Therapy Really a Good Option for BRCA1/2 Mutation Carriers?

  Nilsson, M. & Loman, N., 2016, I: Clinical Oncology. 28, 3, s. 223-24

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review
  2 Citeringar (SciVal)

• Targeted sequencing of BRCA1 and BRCA2 across a large unselected breast cancer cohort suggests that one-third of mutations are somatic

  Winter, C., Nilsson, M. P., Olsson, E., George, A. M., Chen, Y., Kvist, A., Törngren, T., Vallon-Christersson, J., Hegardt, C., Häkkinen, J., Jönsson, G., Grabau, D., Malmberg, M., Kristoffersson, U., Rehn, M., Gruvberger-Saal, S. K., Larsson, C., Borg, Å., Loman, N. & Saal, L. H., 2016 aug, I: Annals of Oncology. 27, 8, s. 1532-8 7 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Breast Neoplasms 100%
  • Mutation 87%
  • Germ-Line Mutation 66%
  • BRCA2 Gene 28%
  • BRCA1 Gene 26%
  52 Citeringar (SciVal)
• 2015

  Comparison of doses and NTCP to risk organs with enhanced inspiration gating and free breathing for left-sided breast cancer radiotherapy using the AAA algorithm.

  Edvardsson, A., Nilsson, M., Amptoulach, S. & Ceberg, S., 2015, I: Radiation Oncology. 10, 1, 84.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  Fil

  • Unilateral Breast Neoplasms 100%
  • Respiration 54%
  • Coronary Vessels 54%
  • Radiotherapy 45%
  • Heart 42%
  12 Citeringar (SciVal)

  163 Nedladdningar (Pure)
• 2014

  High risk of in-breast tumor recurrence after BRCA1/2-associated breast cancer.

  Nilsson, M., Werner Hartman, L., Kristoffersson, U., Johannsson, O. T., Borg, Å., Henriksson, K., Lanke, E., Olsson, H. & Loman, N., 2014, I: Breast Cancer Research and Treatment. 147, 3, s. 571-578 8 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  Fil

  • Breast 100%
  • Breast Neoplasms 95%
  • Recurrence 86%
  • Mutation 31%
  • Therapeutics 24%
  28 Citeringar (SciVal)

  195 Nedladdningar (Pure)

• Long-term prognosis of early-onset breast cancer in a population-based cohort with a known BRCA1/2 mutation status.

  Nilsson, M., Werner Hartman, L., Idvall, I., Kristoffersson, U., Johannsson, O. T. & Loman, N., 2014, I: Breast Cancer Research and Treatment. 144, 1, s. 133-142

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Öppen tillgång

  • Breast Neoplasms 100%
  • Mutation 87%
  • Population 61%
  • Survival 54%
  • Drug Therapy 34%
  17 Citeringar (SciVal)
• 2013

  Biofilm formation by Staphylococcus epidermidis on peritoneal dialysis catheters and the effects of extracellular products from Pseudomonas aeruginosa.

  Pihl, M., Arvidsson, A., Skepö, M., Nilsson, M., Givskov, M., Tolker-Nielsen, T., Svensäter, G. & Davies, J. R., 2013, I: Pathogens and Disease. 67, 3, s. 192-198

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  • Staphylococcus epidermidis 100%
  • Peritoneal Dialysis 91%
  • Biofilms 82%
  • Pseudomonas aeruginosa 78%
  • Catheters 66%
  9 Citeringar (SciVal)
• 2005

  Fusion of the HMGA2 and NFIB genes in lipoma

  Nilsson, M., Panagopoulos, I., Mertens, F. & Mandahl, N., 2005 nov, I: Virchows Archiv: an international journal of pathology. 447, 5, s. 855-858 4 s.

  Forskningsoutput: Tidskriftsbidrag › Artikel i vetenskaplig tidskrift › Peer review

  Fil

  • Lipoma 100%
  • Hamartoma 51%
  • Gene Fusion 47%
  • Exons 34%
  • Pleomorphic Salivary Gland Adenoma 34%
  28 Citeringar (SciVal)

  165 Nedladdningar (Pure)